On the political front, Robert F. Kennedy Jr. will become the next HHS secretary after he attained a majority of Senate votes ...

In a phase 2 study, the company's medication suzetrigine barely performed better than a placebo in treating painful ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on CVS Health (CVS – Research Report) and ...

Most U.S. stocks fell Wednesday after a report showed inflation is unexpectedly worsening for Americans. The S&P 500 dropped 0.3%, though it had been on track for a much worse loss of 1.1% at the ...

Ashok Leyland Ltd., Bharat Forge Ltd., Muthoot Finance Ltd., Natco Pharma Ltd., Kotak Mahindra Bank Ltd., and SBI Cards And ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The company aims to do just that.

Donald Trump’s proposed tariffs have sparked fresh fears of an economic downturn, with investors bracing for potential disruptions to global trade. Historically, protectionist policies can lead to ...

Harvey Jones has something to celebrate after a positive set of results boosted the GSK share price after a disappointing run ...

The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

GSK Plc's U.S.-listed shares surged Wednesday after the pharmaceutical firm boosted its long-term outlook and launched a $2.5 billion stock buyback on the back of optimism about sales of its new drugs ...

Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in licensing deals, on average, than in 2023 with an eye toward enriching their ...